Literature DB >> 3094762

Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus.

R Madhok, A Gracie, G D Lowe, A Burnett, K Froebel, E Follett, C D Forbes.   

Abstract

The cell mediated immune response was evaluated in vivo in 29 patients with clinically severe haemophilia by means of the dinitrochlorobenzene skin test. All patients had a response below the median normal value, and in 19 the response was on or below the lower limit of the normal range. There was no difference in skin response between patients positive and negative for the human immunodeficiency virus (HIV; formerly known as human T cell lymphotropic virus III or lymphadenopathy associated virus). In the whole group, and in seronegative patients (n = 17), there was an inverse relation between exposure to clotting factor and skin response. In seropositive patients (n = 12) no such association was apparent. This study shows that clotting factor concentrate impairs the cell mediated immune response to a new antigen in the absence of infection with HIV.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094762      PMCID: PMC1341772          DOI: 10.1136/bmj.293.6553.978

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition.

Authors:  R Edelman; R Suskind; R E Olson; S Sirisinha
Journal:  Lancet       Date:  1973-03-10       Impact factor: 79.321

Review 2.  AIDS--an immunologic reevaluation.

Authors:  M Seligmann; L Chess; J L Fahey; A S Fauci; P J Lachmann; J L'Age-Stehr; J Ngu; A J Pinching; F S Rosen; T J Spira
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

3.  Retroviruses linked with AIDS.

Authors:  R Weiss
Journal:  Nature       Date:  1984 May 3-9       Impact factor: 49.962

Review 4.  Structural Aspects and Heterogeneity of Immunoglobulin Fc Receptors.

Authors:  J C Unkeless; H Fleit; I S Mellman
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

5.  Endogenous cell-mediated immunity, blood transfusion, and outcome of renal transplantation.

Authors:  M A Watson; J D Briggs; A A Diamandopoulos; D N Hamilton; H M Dick
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

6.  Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.

Authors:  C A Ludlam; J Tucker; C M Steel; R S Tedder; R Cheingsong-Popov; R A Weiss; D B McClelland; I Philp; R J Prescott
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

7.  Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?

Authors:  K S Froebel; R Madhok; C D Forbes; S E Lennie; G D Lowe; R D Sturrock
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

8.  Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation.

Authors:  J A Levy; J L Ziegler
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

9.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

10.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  13 in total

Review 1.  Effects of factor VIII concentrates on the immune system in hemophilic patients.

Authors:  S Schulman
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

2.  Histometric studies on cellular infiltrates of tuberculin tests in patients with haemophilia.

Authors:  J G Lowe; J S Beck; R Madhok; A Gracie; J H Gibbs; R C Potts; G D Lowe; C D Forbes
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

3.  Extranodal lymphoma in a haemophiliac negative for antibody to HIV.

Authors:  R Madhok; G D Lowe; C D Forbes; C J Stewart; F Lee
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-14

Review 4.  Humoral immune response to influenza vaccination in patients from high risk groups.

Authors:  L B Brydak; M Machala
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

5.  Diversity in migration of CD4 and CD8 lymphocytes in different microanatomical compartments of the skin in the tuberculin reaction in man.

Authors:  J S Beck; S M Morley; J G Lowe; R A Brown; J M Grange; J H Gibbs; R C Potts; T Kardjito
Journal:  Br J Exp Pathol       Date:  1988-12

6.  Comparison of immunodeficiency and AIDS defining conditions in HIV negative and HIV positive men with haemophilia A.

Authors:  C A Sabin; K J Pasi; A N Phillips; P Lilley; M Bofill; C A Lee
Journal:  BMJ       Date:  1996-01-27

7.  Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV).

Authors:  R A Sharp; S M Morley; J S Beck; G E Urquhart
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

Review 8.  Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; D Causer
Journal:  Genetica       Date:  1995       Impact factor: 1.082

Review 9.  Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.

Authors:  P H Duesberg
Journal:  Genetica       Date:  1995       Impact factor: 1.082

10.  A rare case of acute lymphoblastic leukaemia with hemophilia A.

Authors:  Rahul Sinha; Kirandeep Sodhi; Biju John; Daljit Singh
Journal:  Ital J Pediatr       Date:  2009-12-11       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.